SCA
INFI

Secor Capital Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Secor Capital Advisors’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-36,408
Closed -$308K – 667
2015
Q3 		$308K Buy
36,408
+2,857
+9% +$26.4K 0.1% 346
2015
Q2 		$367K Buy
+33,551
New +$431K 0.13% 265
2015
Q1 		– Sell
-32,803
Closed -$554K – 560
2014
Q4 		$554K Buy
32,803
+12,532
+62% +$182K 0.23% 160
2014
Q3 		$272K Buy
+20,271
New +$241K 0.15% 236

Other funds holding INFI

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Secor Capital Advisors's INFI Position: Q4 2015 in Review

Secor Capital Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2015, closing a stake of 36,408 shares — an estimated $308K sold.

Secor Capital Advisors first reported a position in INFI in Q3 2014 and held it in 4 quarters. The position peaked at $554K in Q4 2014. 115 funds tracked by Wall St. Rank hold INFI as of Q4 2015.

  • Secor Capital Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Secor Capital Advisors sold 36,408 Infinity Pharmaceuticals, Inc. shares in Q4 2015, an estimated $308K.
  • Secor Capital Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2014 and held it in 4 quarters.
  • Secor Capital Advisors's Infinity Pharmaceuticals, Inc. position peaked at $554K in Q4 2014.
  • 115 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2015.

Based on Secor Capital Advisors's 13F filing for Q4 2015, filed 8 Feb 2016.